关注
Anand S Bhagwat
Anand S Bhagwat
Heme/Onc Fellow, Children’s Hospital of Philadelphia
在 email.chop.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
In vivo genome editing restores haemostasis in a mouse model of haemophilia
H Li, V Haurigot, Y Doyon, T Li, SY Wong, AS Bhagwat, N Malani, ...
Nature 475 (7355), 217-221, 2011
7582011
Targeting transcription factors in cancer
AS Bhagwat, CR Vakoc
Trends in cancer 1 (1), 53-65, 2015
3182015
BET bromodomain inhibition releases the mediator complex from select cis-regulatory elements
AS Bhagwat, JS Roe, BYL Mok, AF Hohmann, J Shi, CR Vakoc
Cell reports 15 (3), 519-530, 2016
1772016
The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer
E Wang, S Kawaoka, JS Roe, J Shi, AF Hohmann, Y Xu, AS Bhagwat, ...
Elife 4, e06377, 2015
472015
Enhancer dysfunction in leukemia
AS Bhagwat, B Lu, CR Vakoc
Blood, The Journal of the American Society of Hematology 131 (16), 1795-1804, 2018
392018
High-throughput screening and biophysical interrogation of hepatotropic AAV
SL Murphy, A Bhagwat, S Edmonson, S Zhou, KA High
Molecular Therapy 16 (12), 1960-1967, 2008
252008
A new bump in the epigenetic landscape
AS Bhagwat, CR Vakoc
Molecular cell 53 (6), 857-858, 2014
62014
Cytokine release syndrome results in reduced AML killing by CD123 CAR T cells
AS Bhagwat, L Torres, O Shestova, M Shestov, NV Frey, EO Hexner, ...
Blood 142, 217, 2023
52023
Cytokine-mediated CAR T therapy resistance in AML
AS Bhagwat, L Torres, O Shestova, M Shestov, PW Mellors, HR Fisher, ...
Nature Medicine, 1-12, 2024
2024
Do Not Pass on GO in Childhood KMT2A-Rearranged AML (and Collect 20% Improvement in EFS)
A Bhagwat, SK Tasian
The Hematologist 19 (3), 3149-3160, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–10